Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial
Carlos Collet, Thabo Mahendiran, William F. Fearon, Takuya Mizukami et autres
11 citationsNature Medicine